Kentaro Suzuki Biography and Net Worth

Ken is a seasoned product and marketing leader who joins Nautilus from Agilent Technologies where he most recently served as Vice President and General Manager of Agilent’s Mass Spectrometry division. He held several leadership positions during his twenty-five years at Agilent, including Vice President of Global Marketing for CrossLab Services and Support, Vice President and General Manager of Strategic Program Office, and Agilent Certified Pre-Owned Instruments and Associate VP of Marketing in Spectroscopy. His track record in the life sciences and technology sector spans nearly three decades across marketing, strategic program management, finance, and research and development. Previously, he held roles in applications and sales at Takeda Pharmaceuticals in Tokyo, Japan, and in finance at Hewlett-Packard (HP) before contributing to the founding of Agilent. Ken received his M.B.A. from the Haas School of Business at the University of California, Berkeley, and his B.S. in Biological Engineering from Cornell University.

What is Kentaro Suzuki's net worth?: The estimated net worth of Kentaro Suzuki is at least $15.06 thousand as of November 6th, 2025. Suzuki owns 4,000 shares of Nautilus Biotechnology stock worth more than $15,060 as of March 24th. This net worth evaluation does not reflect any other investments that Suzuki may own. Learn More about Kentaro Suzuki's net worth.
How do I contact Kentaro Suzuki?: The corporate mailing address for Suzuki and other Nautilus Biotechnology executives is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. Nautilus Biotechnology can also be reached via phone at 206-333-2001 and via email at [email protected]. Learn More on Kentaro Suzuki's contact information.
Has Kentaro Suzuki been buying or selling shares of Nautilus Biotechnology?: Kentaro Suzuki has not been actively trading shares of Nautilus Biotechnology in the last ninety days. Most recently, on Thursday, November 6th, Kentaro Suzuki bought 4,000 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $1.49 per share, with a total value of $5,960.00. Following the completion of the transaction, the chief marketing officer now directly owns 4,000 shares of the company's stock, valued at $5,960. Learn More on Kentaro Suzuki's trading history.
Who are Nautilus Biotechnology's active insiders?: Nautilus Biotechnology's insider roster includes Mary Godwin (VP), Matthew Mcilwain (Director), Anna Mowry (CFO), Matthew Murphy (General Counsel), Sujal Patel (CEO), Matthew Posard (Director), and Kentaro Suzuki (CMO). Learn More on Nautilus Biotechnology's active insiders.
Are insiders buying or selling shares of Nautilus Biotechnology?: In the last year, Nautilus Biotechnology insiders bought shares 8 times. They purchased a total of 277,500 shares worth more than $240,250.00. The most recent insider tranaction occured on March, 4th when CEO Sujal M Patel bought 25,000 shares worth more than $65,250.00. Insiders at Nautilus Biotechnology own 41.1% of the company. Learn More about insider trades at Nautilus Biotechnology.
Information on this page was last updated on 3/4/2026.

Kentaro Suzuki Insider Trading History at Nautilus Biotechnology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/6/2025	Buy	4,000	$1.49	$5,960.00	4,000

Kentaro Suzuki Buying and Selling Activity at Nautilus Biotechnology

Nautilus Biotechnology Company Overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Today's Range

Now: $3.95

$3.50

$3.98

50 Day Range

MA: $2.35

$1.83

$3.62

2 Week Range

Now: $3.95

$0.62

$3.98

Volume

1,131,274 shs

Average Volume

249,942 shs

Market Capitalization

$499.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44